Randomized phase II-III study of chemoradiation with fluorouracil and cisplatin versus chemotherapy (gemcitabine/oxaliplatin) in non resectable but non metastatic cancer of the biliary tract
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Fluorouracil; Gemcitabine; Oxaliplatin
- Indications Biliary cancer; Biliary tract disorders
- Focus Therapeutic Use
- 30 May 2016 Biomarkers information updated
- 02 Oct 2012 Results presented at the 37th Congress of the European Society for Medical Oncology.
- 02 Oct 2012 Status changed from recruiting to discontinued based on results presented at the 37th Congress of the European Society for Medical Oncology. The study was closed before completion of the planned number of patients due to slow accrual.